Growth response to antiretroviral treatment in HIV-infected children: A cohort study from Lilongwe, Malawi

Tropical Medicine and International Health

Volumn 15, Issue 8, 2010, Pages 934-944

  Weigel, Ralf ^a   Phiri, Sam ^a   Chiputula, Fred ^a   Gumulira, Joe ^a   Brinkhof, Martin ^b   Gsponer, Thomas ^b   Tweya, Hannock ^a   Egger, Matthias ^b   Keiser, Olivia ^b  

^a KAMUZU CENTRAL HOSPITAL   (Malawi)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

antiretroviral therapy; children; growth; HIV infection; Malawi

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

CHILD HEALTH; GROWTH RESPONSE; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MULTIVARIATE ANALYSIS; RISK FACTOR;

AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; FEMALE; GROWTH CURVE; GROWTH RETARDATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALAWI; MALE; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

ANTHROPOMETRY; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY HEIGHT; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; GROWTH; GROWTH DISORDERS; HIV INFECTIONS; HUMANS; MALAWI; MALE; MALNUTRITION; PROGNOSIS; TREATMENT OUTCOME;

LILONGWE; MALAWI;

EID: 77954721435     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02561.x     Document Type: Article

References (42)

1. Arrive E, Kyabayinze DJ, Marquis B et al. (2008) Cohort profile: the paediatric antiretroviral treatment programmes in clower-income countries (KIDS-ART-LINC) collaboration. International Journal of Epidemiology 37, 474 480.
2. Bandyopadhyay A Bhattacharyya S (2008) Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy. Annals of Tropical Paediatrics 28, 279 285.
3. Benjamin DK Jr., Miller WC, Benjamin DK et al. (2003) A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS 17, 2331 2336.
4. Benjamin DK Jr., Hirschfeld S, Cunningham CK McKinney RE Jr. (2004a) Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials. Journal of Antimicrobial Chemotherapy 54, 701 703.
5. Benjamin DK Jr., Miller WC, Ryder RW et al. (2004b) Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings. AIDS Patient Care and STDS 18, 35 43.
6. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Journal of the American Medical Association 298, 1888 1899.
7. Bong CN, Yu JK, Chiang HC et al. (2007) Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS 21, 1805 1810.
8. Chinkhumba J, Tomkins A, Banda T, Mkangama C Fergusson P (2008) The impact of HIV on mortality during in-patient rehabilitation of severely malnourished children in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 639 644.
9. 3Cs4kids collaboration (2008) Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 22, 97 105.
10. Ellis J Molyneux EM (2007) Experience of anti-retroviral treatment for HIV-infected children in Malawi: the 1st 12 months. Annals of Tropical Paediatrics 27, 261 267.
11. Fassinou P, Elenga N, Rouet F et al. (2004) Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 18, 1905 1913.
12. Fergusson P, Chinkhumba J, Grijalva-Eternod C et al. (2009) Nutritional recovery in HIV infected and uninfected children with severe acute malnutrition. Archives of Disease in Childhood 94, 512 516.
13. Filteau S (2009) The HIV-exposed, uninfected African child. Tropical Medicine and International Health 14, 276 287.
14. Guillen S, Ramos JT, Resino R, Bellon JM Munoz MA (2007) Impact on weight and height with the use of HAART in HIV-infected children. Pediatric Infectious Disease Journal 26, 334 338.
15. Hamill PV, Drizd TA, Johnson CL, Reed RB Roche AF (1977) NCHS growth curves for children birth-18 years. United States. Vital and Health Statistics. Series 11, 165, 1 74.
16. Heikens GT, Bunn J, Amadi B et al. (2008) Case management of HIV-infected severely malnourished children: challenges in the area of highest prevalence. Lancet 371, 1305 1307.
17. Kabue MM, Kekitiinwa A, Maganda A et al. (2008) Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care and STDS 22, 245 251.
18. Kekitiinwa A, Lee KJ, Walker AS et al. (2008) Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. Journal of Acquired Immune Deficiency Syndromes 49, 384 392.
19. Kessler L, Daley H, Malenga G Graham S (2000) The impact of the human immunodeficiency virus type 1 on the management of severe malnutrition in Malawi. Annals of Tropical Paediatrics 20, 50 56.
20. Laufer MK, van Oosterhout JJ, Perez MA et al. (2006) Observational cohort study of HIV-infected African children. Pediatric Infectious Disease Journal 25, 623 627.
21. Lunn DJ, Thomas A, Best N Spiegelhalter D (2010) WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing 10, 325 337.
22. Ministry of Health of Malawi (2003) Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi, 1st edn. Government of Malawi, Lilongwe.
23. Ministry of Health of Malawi (2006a) Interim Guidelines for the Management of Acute Malnutrition in Adolescents and Adults. Government of Malawi and UNICEF
24. Ministry of Health of Malawi (2006b) Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi, 2nd edn. Government of Malawi
25. Ministry of Health of Malawi (2008) ANC Sentinel Surveillance and National HIV Prevalence and AIDS Estimates 2007. Government of Malawi.
26. Muula AS, Chipeta J, Siziya S et al. (2007) Human resources requirements for highly active antiretroviral therapy scale-up in Malawi. BMC Health Serv Res 7, 208.
27. Nachman SA, Lindsey JC, Moye J et al. (2005) Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatric Infectious Disease Journal 24, 352 357.
28. National Statistical Office (NSO) [Malawi] and ORC Macro (2005) Malawi Demographic and Health Survey 2004. NSO and ORC Macro
29. Nyandiko WM, Ayaya S, Nabakwe E et al. (2006) Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. Journal of Acquired Immune Deficiency Syndromes 43, 418 425.
30. Royston P Altman DG (1994) Regression using fractional polynominals of continuous covariates: parsimonious parametric modelling. Applied Statistics 43, 429 467.
31. Song R, Jelagat J, Dzombo D et al. (2007) Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya. Pediatrics 120, e856 e861.
32. Steiner F, Kind C, Aebi C et al. (2001) Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors. European Journal of Pediatrics 160, 611 616.
33. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D Moss WJ (2008) Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. The Lancet Infectious Diseases 8, 477 489.
34. The R Development Core Team (2009) R: A Language and Environment for. Statistical Computing. Reference Index. Version 2.10.1. Available at : http://cran.r-project.org/doc/manuals/refman.pdf (accessed 21 March 2010).
35. Thurstans S, Kerac M, Maleta K, Banda T Nesbitt A (2008) HIV prevalence in severely malnourished children admitted to nutrition rehabilitation units in Malawi: geographical & seasonal variations a cross-sectional study. BMC Pediatrics 8, 22.
36. Verweel G, van Rossum AM, Hartwig NG et al. (2002) Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 109, E25.
37. Walker AS, Mulenga V, Ford D et al. (2007) The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clinical Infectious Diseases 44, 1361 1367.
38. Wamalwa DC, Farquhar C, Obimbo EM et al. (2007) Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. Journal of Acquired Immune Deficiency Syndromes 45, 311 317.
39. WHO (2004) Scaling up Antiretroviral Therapy in Resource- Limited Settings: Treatment Guidelines for a Public Health Approach. 2003 Revision. WHO
40. WHO (2006) Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access Recommendations for a Public Health Approach. WHO
41. WHO (2010a). Growth Reference Data for 5-19 years. Last updated 2010. Available at : http://www.who.int/growthref/en/ (accessed 21 March 2010).
42. WHO (2010b). WHO Child Growth Standards. Last updated 2010. Available at : http://www.who.int/childgrowth/standards/en/ (accessed 21 March 2010).